Phase 2 Study With SNF472 in Calciphylaxis Patients

Summary

To evaluate the effect of SNF472 on top of standard of care on promoting wound healing and other parameters of therapeutic response in haemodialysis patients with calciphylaxis (calcific uraemic arteriolopathy, CUA).

Timeline

Start

2016-05

Primary completion

2017-11-15

Completion

2017-11-15

Drugs

Indications